Literature Archives

Successful pleurodesis is an independent predictor of improved overall survival, with a three-month landmark hazard ratio of 0.23 (P < 0.001). Interventional pulmonologists should prioritize timely, effective pleural procedures to achieve durable pleurodesis success and modify the disease course beyond immediate palliation.

Flexible bronchoscopy with bronchial forceps serves as an effective initial management strategy for aspirated dental objects, achieving a 75% initial retrieval success rate.

While 93% of pleural diagnoses can be established with 3 or fewer biopsies, interventional pulmonologists should tailor their sampling strategy based on pleural morphology and the need for biomarker profiling.

Minor esophageal mucosal alterations occur in 89.2 percent of EUS-B-FNA procedures, but they are benign and clinically insignificant when performed by experienced interventional pulmonologists, supporting its continued safe use in thoracic staging.

Accurate CPT coding and meticulous documentation are critical for interventional pulmonologists to ensure proper reimbursement, reflect procedural complexity, and safeguard against billing compliance audits, though specific numerical data were not evaluated in this qualitative review.

Relevant for staging and selecting patients who may require bronchoscopic mediastinal staging (like EBUS).

Advanced robotic-assisted bronchoscopy makes sampling multiple lung nodules in a single session safe and essential, proving that concurrent nodules do not always share the same pathology.

Highlights the balance between achieving clinical benefit in COPD symptom reduction and managing bronchoscopy-related adverse events with TLD.

Targeted lung denervation continues to evolve as a bronchoscopic treatment option for select COPD phenotypes, requiring careful patient selection.

Highlights methodological caveats to consider when interpreting clinical trial data for bronchoscopic denervation procedures.

Patient selection for bronchoscopic targeted lung denervation in COPD requires deeper physiologic and phenotypic understanding.

Relevant to bronchoscopic interventions for COPD, specifically targeted lung denervation patient selection and management.